Poland

PolTREG Receives CGMP Certification to Produce Cell Therapies at Its Advanced Manufacturing Site in Poland

Gdańsk, Poland – March 11, 2024 – PolTREG S. A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing mobile treatments for a variety of autoimmune diseases, announces that it has obtained CGMP certification from Poland’s Chief Pharmaceutical Inspectorate. , allowing it to produce advanced therapy drugs (ATMPs) in its own facilities. Certification also allows you to apply for authorization from the Polish Office for the Registration of Medical Products.

PolTREG Receives CGMP Certification to Produce Cell Therapies at Its Advanced Manufacturing Site in Poland Read More »